Envision Healthcare Holdings, Inc. (NYSE:EVHC) closed its last session at $25.70 with the change of +2.64%. The market capitalization of the company is $4.81B with an average Volume of 2.98 million shares. The stock currently has its 52-Week High range of $45.95 and 52-week low range of $18.31. The Price to Book (P/B) ratio stands at 2.35. The stock traded total quantity of 4.14 million shares.
For the current Fiscal Quarter, 18 analysts have given an average earnings per share forecast of $0.36. The Low Earnings per share estimate of the current Quarter is $0.31 and High Estimate is set at $0.4 according to these Analysts opinions. The Previous Year EPS of this Quarter is $0.37.
According to 14 analysts, an average sales Estimate of the current Fiscal quarter is $1.66B. The lower sales estimate is $1.57B and higher sales estimate is $1.76B according to these Analysts thoughts.
The Company currently has Highest Price Target of $36 and Lowest Price Target of $27. It has Median Price Targets of $31. Mean price target is set at $31.13 after consensus analysis of 15 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 0 analysts have assigned this stock as Strong Buy where 0 assigned Buy, 0 analysts believe it’s a Hold, 7 said Underperform and 5 assigned Sell rating.
Biogen Inc. (NASDAQ:BIIB) ended its last trade at $251.30 with the move of +1.63%. The company has market value of $55.05B with the total traded volume of 1.3 million. The stock currently has its 52-Week top value of $412.24 and 52-week down value of $223.02. The price to book (P/B) ratio of the company is 5.25. Its previous closing price was recorded at $247.27.
For the current Fiscal Quarter, 21 analysts have given an Average earnings estimate of $4.68 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $4.37 while High Estimate is $5.29. The Previous Year EPS of this Quarter is $4.22.
According to 18 analysts, an Average Revenue Estimate of the current Fiscal quarter is $2.80B. According to them, the Low Revenue estimate is $2.73B and High Revenue estimate is $2.94B.
The Company currently has High Price Target of $401. The Low and Mean Price Targets are $267 and $332.47 respectively. These price targets are set after consensus analysis of 19 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 0 analysts have given this stock as Strong Buy where 0 issued Buy, 0 analysts think that it’s a Hold, 6 told Underperform and8 assigned Sell rating.